Editing Genetics of chronic fatigue syndrome
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 1: | Line 1: | ||
The '''genes''' linked to [[myalgic encephalomyelitis]]/[[chronic fatigue syndrome]] is an area of research as [[ME/CFS]] has been observed in families.<ref name="cdc2018">{{Cite web | url=https://www.cdc.gov/me-cfs/healthcare-providers/presentation-clinical-course/etiology-pathophysiology.html | title = Etiology and Pathophysiology {{!}} Presentation and Clinical Course {{!}} Healthcare Providers {{!}} Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | date = 2018-11-08 | website = [[Centers for Disease Control and Prevention]]|language=en-us|access-date=2019-02-08}}</ref> It is unknown if there is a genetic link or common environmental exposure (infectious or toxic). Studies of twins show higher rates of ME/CFS in identical than fraternal twins. The [[Centers for Disease Control and Prevention]] (CDC) notes that specific genetic associations have not been established.<ref name="cdc2018" /> | The '''genes''' linked to [[myalgic encephalomyelitis]]/[[chronic fatigue syndrome]] is an area of research as [[ME/CFS]] has been observed in families.<ref name="cdc2018">{{Cite web|url=https://www.cdc.gov/me-cfs/healthcare-providers/presentation-clinical-course/etiology-pathophysiology.html | title = Etiology and Pathophysiology {{!}} Presentation and Clinical Course {{!}} Healthcare Providers {{!}} Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | date = 2018-11-08 | website = [[Centers for Disease Control and Prevention]]|language=en-us|access-date=2019-02-08}}</ref> It is unknown if there is a genetic link or common environmental exposure (infectious or toxic). Studies of twins show higher rates of ME/CFS in identical than fraternal twins. The [[Centers for Disease Control and Prevention]] (CDC) notes that specific genetic associations have not been established.<ref name="cdc2018" /> | ||
=== The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS === | === The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS === | ||
Line 27: | Line 27: | ||
A review by Dibble, [[Simon McGrath|McGrath]] and [[Chris Ponting|Ponting]] (2020) in preparation for the [[DecodeME]] study stated that research on the UK Biobank patient data showed associations for [[SLC25A15]] (rs7337312), [[P4HA1]] (rs150954845), [[EBF3]] (rs148723539) and [[COX7B2]] (rs564809936).<ref name="Dibble2020" /> | A review by Dibble, [[Simon McGrath|McGrath]] and [[Chris Ponting|Ponting]] (2020) in preparation for the [[DecodeME]] study stated that research on the UK Biobank patient data showed associations for [[SLC25A15]] (rs7337312), [[P4HA1]] (rs150954845), [[EBF3]] (rs148723539) and [[COX7B2]] (rs564809936).<ref name="Dibble2020" /> | ||
The largest genetic study of ME/CFS patients was published by Hajdarevic et al. in 2022; and analysed data from over 2,500 patients from the UK Biobank, Norway and Denmark, reported they "did not find any ME/CFS risk loci displaying genome-wide significance". The study did find that the [[tubulin polymerization promoting protein|Tubulin Polymerization Promoting Protein]] (TPPP) region may be implicated in ME/CFS.<ref name="Hajdarevic2022" /><ref name="TPPP">{{Cite web | url=https://www.genecards.org/cgi-bin/carddisp.pl?gene=TPPP | title = TPPP Gene {{!}} TPPP Protein {{!}} TPPP Antibody | last = | first = | authorlink = | date = | website = GeneCards|archive-url=|archive-date=|url-status=|access-date=2022-03-29}}</ref> TPPP is an antibody expressed in the [[brain]]. Other genes identified [[LINC00333]], [[RIN3]], [[IGFBP1]]/[[IGFBP3]], [[IZUMO1]]/[[FUT1]] and [[ZBTB46]] but [[Protein tyrosine phosphatase non-receptor type 22|PTPN22]] and [[Cytotoxic T-lymphocyte associated protein 4|CTLA4]] genes reported in previous research did not show significance.<ref name="Hajdarevic2022" /> Hajdarevic and colleagues found more significant associations within the Norwegian cohort, who (like the Danish cohort) were diagnosed using the strict [[Canadian Consensus Criteria]], whereas the majority of data came from UK patient self-reported diagnosis. They commented that statistical significance would need approximately 10 times more patient data, which the [[DecodeME]] project was hoped to provide.<ref name="Hajdarevic2022" /> | The largest genetic study of ME/CFS patients was published by Hajdarevic et al. in 2022; and analysed data from over 2,500 patients from the UK Biobank, Norway and Denmark, reported they "did not find any ME/CFS risk loci displaying genome-wide significance". The study did find that the [[tubulin polymerization promoting protein|Tubulin Polymerization Promoting Protein]] (TPPP) region may be implicated in ME/CFS.<ref name="Hajdarevic2022" /><ref name="TPPP">{{Cite web|url=https://www.genecards.org/cgi-bin/carddisp.pl?gene=TPPP | title = TPPP Gene {{!}} TPPP Protein {{!}} TPPP Antibody | last = | first = | authorlink = | date = | website = GeneCards|archive-url=|archive-date=|url-status=|access-date=2022-03-29}}</ref> TPPP is an antibody expressed in the [[brain]]. Other genes identified [[LINC00333]], [[RIN3]], [[IGFBP1]]/[[IGFBP3]], [[IZUMO1]]/[[FUT1]] and [[ZBTB46]] but [[Protein tyrosine phosphatase non-receptor type 22|PTPN22]] and [[Cytotoxic T-lymphocyte associated protein 4|CTLA4]] genes reported in previous research did not show significance.<ref name="Hajdarevic2022" /> Hajdarevic and colleagues found more significant associations within the Norwegian cohort, who (like the Danish cohort) were diagnosed using the strict [[Canadian Consensus Criteria]], whereas the majority of data came from UK patient self-reported diagnosis. They commented that statistical significance would need approximately 10 times more patient data, which the [[DecodeME]] project was hoped to provide.<ref name="Hajdarevic2022" /> | ||
==Notable studies== | ==Notable studies== |